Rheolytic Thrombectomy with or without Adjunctive Indwelling Pharmacolysis in Patients Presenting with Acute Pulmonary Embolism Presenting with Right Heart Strain and/or Pulseless Electrical Activity

Table 1

Cardiopulmonary status and Possis Angiojet and technical details.

Patients	Cardioplumonary status			Possis Angiojet mode		tPA dose and administration route
	Miller score	PEA/code	RV-strain	Pulse- spray	Aspiration	Intra-op tPA	Indwelling catheter tPA	Total tPA Dose
Patient #1	25	No	CTPA + Echo	No	Yes	4 mg	12 mg	16 mg
Patient #2	17	Yes	CTPA + Echo	No	Yes	8 mg	21 mg	29 mg
Patient #3	21	Yes	CTPA	Yes	Yes	8 mg	14 mg	22 mg
Patient #4	16	Yes	CTPA + Echo	Yes	Yes	6 mg	21 mg	27 mg
Patient #5*	26	No	CTPA + Echo	No	Yes	No	No	No
Patient #6	24	No	CTPA + Echo	Yes	No	10 mg	14 mg	24 mg
Patient #7	25	No	CTPA	Yes	Yes	8 mg	18 mg	26 mg
Patient #8	27	No	Echo	No	Yes + T	No	No**	No**
Patient #9	25	No	CTPA + Echo	Yes	No	8 mg	26 mg	34 mg
Patient #10	24	No	Echo	No	Yes	4 mg	31.5 mg	35.5 mg
Patient #11	25	No	Echo	No	Yes + T***	Patient Died

*Patient had glioblastoma multiform (GBM) and was contraindicated to fibrinolysis.
**Patient had active epistaxis and did no undergo postprocedural catheter-directed fibrinolysis.
***The intention was to use aspiration Possis rheolytic, however, patient died on the table prior to its use. An Arrow-Trerotola PTD device was used (Arrow Intl. Inc. Reading, Pa).
+T: Arrow-Trerotola PTD device used (Arrow Intl. Inc. Reading, Pa).